1306.17 -18.28 (-1.38%) | 03-18 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 1593.84 | 1-year : | 1861.6 |
Resists | First : | 1364.58 | Second : | 1593.84 |
Pivot price | 1289.47 | |||
Supports | First : | 1221.75 | Second : | 1133.45 |
MAs | MA(5) : | 1304.54 | MA(20) : | 1265.9 |
MA(100) : | 1158.16 | MA(250) : | 1241.89 | |
MACD | MACD : | 29.5 | Signal : | 27.6 |
%K %D | K(14,3) : | 67.1 | D(3) : | 66.3 |
RSI | RSI(14): 59.4 | |||
52-week | High : | 1615.96 | Low : | 928.5 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ MTD ] has closed below upper band by 37.6%. Bollinger Bands are 14% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 1330.05 - 1336.6 | 1336.6 - 1341.91 |
Low: | 1286.39 - 1295.38 | 1295.38 - 1302.66 |
Close: | 1293.72 - 1307.18 | 1307.18 - 1318.1 |
Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection, x-ray, checkweighing, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of networked scales and software, stand-alone scales, and automated packaging and labeling solutions for handling fresh goods. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
Tue, 19 Mar 2024
Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by Nordea Investment Management AB - MarketBeat
Tue, 19 Mar 2024
Anchor Investment Management LLC Invests $79000 in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
Mon, 18 Mar 2024
Mettler-Toledo International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Mon, 18 Mar 2024
Public Sector Pension Investment Board Raises Holdings in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
Mon, 18 Mar 2024
Comerica Bank Purchases New Shares in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
Fri, 15 Mar 2024
Mettler-Toledo International (NYSE:MTD) Upgraded to Buy at StockNews.com - MarketBeat
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NYSE
|
|
Sector:
Healthcare
|
|
Industry:
Diagnostics & Research
|
|
Shares Out | 0 (M) |
Shares Float | 21 (M) |
Held by Insiders | 2.112e+007 (%) |
Held by Institutions | 1.5 (%) |
Shares Short | 321 (K) |
Shares Short P.Month | 0 (K) |
EPS | 1.16e+009 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | -28.21 |
Profit Margin | 5.6 % |
Operating Margin | 20.8 % |
Return on Assets (ttm) | 28.4 % |
Return on Equity (ttm) | 19.8 % |
Qtrly Rev. Growth | 3.79e+009 % |
Gross Profit (p.s.) | -10.09 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 35.8 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 966 (M) |
PE Ratio | 0 |
PEG Ratio | 29.6 |
Price to Book value | -46.32 |
Price to Sales | 0 |
Price to Cash Flow | -215.51 |
Dividend | 0 |
Forward Dividend | 477990 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |